Literature DB >> 15240612

Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition.

L J Moran1, M Noakes, P M Clifton, G A Wittert, L Tomlinson, C Galletly, N D Luscombe, R J Norman.   

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine condition in women of reproductive age associated with obesity. It may involve dysregulation of ghrelin, a hormone implicated in appetite regulation. The effect of diet composition on ghrelin is unclear. Overweight women with and without PCOS were randomized to a high-protein (40% carbohydrate, 30% protein; 10 PCOS, six non-PCOS) or standard protein diet (55% carbohydrate, 15% protein; 10 PCOS, six non-PCOS) for 12 wk of energy restriction and 4 wk of weight maintenance. Diet composition had no effect on fasting or postprandial ghrelin or measures of satiety. Non-PCOS subjects had a 70% higher fasting baseline ghrelin (P = 0.011), greater increase in fasting ghrelin (57.5 vs. 34.0%, P = 0.033), and greater maximal decrease in postprandial ghrelin after weight loss (-144.1 +/- 58.4 vs. -28.9 +/- 14.2 pg/ml, P = 0.02) than subjects with PCOS. Subjects with PCOS were less satiated (P = 0.001) and more hungry (P = 0.007) after a test meal at wk 0 and 16 than subjects without PCOS. Appetite regulation, as measured by subjective short-term hunger and satiety and ghrelin homeostasis, may be impaired in PCOS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240612     DOI: 10.1210/jc.2003-031583

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  Obesity and Polycystic Ovary Syndrome.

Authors:  Susan Sam
Journal:  Obes Manag       Date:  2007-04

2.  Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome.

Authors:  Margaret C Garin; Samantha F Butts; David B Sarwer; Kelly C Allison; Suneeta Senapati; Anuja Dokras
Journal:  Endocrine       Date:  2016-12-21       Impact factor: 3.633

3.  Effect of Treatment with Metformin on Omentin-1, Ghrelin and other Biochemical, Clinical Features in PCOS Patients.

Authors:  Mahmud Shaker; Zohair I Al Mashhadani; Atheer A Mehdi
Journal:  Oman Med J       Date:  2010-10

Review 4.  Sex differences in the physiology of eating.

Authors:  Lori Asarian; Nori Geary
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-31       Impact factor: 3.619

5.  Study of Omentin1 and Other Adipokines and Hormones in PCOS Patients.

Authors:  Atheer Mahde; Mahmud Shaker; Zohair Al-Mashhadani
Journal:  Oman Med J       Date:  2009-04

Review 6.  Comparison of dietary intake and physical activity between women with and without polycystic ovary syndrome: a review.

Authors:  Annie W Lin; Marla E Lujan
Journal:  Adv Nutr       Date:  2014-09       Impact factor: 8.701

7.  Imbalance Between Postprandial Ghrelin and Insulin Responses to an Ad Libitum Meal in Obese Women With Polycystic Ovary Syndrome.

Authors:  Camila Cremonezi Japur; Rosa Wanda Diez-Garcia; Fernanda Rodrigues de Oliveira Penaforte; Marcos Felipe Silva de Sá
Journal:  Reprod Sci       Date:  2014-02-11       Impact factor: 3.060

Review 8.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

9.  The effect of ingested macronutrients on postprandial ghrelin response: a critical review of existing literature data.

Authors:  Chrysi Koliaki; Alexander Kokkinos; Nicholas Tentolouris; Nicholas Katsilambros
Journal:  Int J Pept       Date:  2010-02-02

10.  Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome.

Authors:  D Micic; M Sumarac-Dumanovic; A Kendereski; G Cvijovic; S Zoric; D Pejkovic; J Micic; N Milic; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.